For example, the angiotensin II type 1 receptor blocker losartan inhibits fibrosis and improves the disease in mouse models for Duchenne muscular dystrophy and LAMA2 MD [5–7]. Here, AGTR1 is linked to Duchenne muscular dystrophy.